129 related articles for article (PubMed ID: 32128758)
1. Physiologically-Based Pharmacokinetic Model of Sertraline in Human to Predict Clinical Relevance of Concentrations at Target Tissues.
Alhadab AA; Brundage RC
Clin Pharmacol Ther; 2020 Jul; 108(1):136-144. PubMed ID: 32128758
[TBL] [Abstract][Full Text] [Related]
2. Population Pharmacokinetics of Sertraline in Healthy Subjects: a Model-Based Meta-analysis.
Alhadab AA; Brundage RC
AAPS J; 2020 May; 22(4):73. PubMed ID: 32430638
[TBL] [Abstract][Full Text] [Related]
3. Application of physiologically based pharmacokinetic modeling for sertraline dosing recommendations in pregnancy.
George B; Lumen A; Nguyen C; Wesley B; Wang J; Beitz J; Crentsil V
NPJ Syst Biol Appl; 2020 Nov; 6(1):36. PubMed ID: 33159093
[TBL] [Abstract][Full Text] [Related]
4. Clinical pharmacokinetics of sertraline.
DeVane CL; Liston HL; Markowitz JS
Clin Pharmacokinet; 2002; 41(15):1247-66. PubMed ID: 12452737
[TBL] [Abstract][Full Text] [Related]
5. Comparative bioavailability of two sertraline tablet formulations in healthy human volunteers after a single dose administration.
Moraes ME; Lerner FE; Perozin M; Moraes MO; Frota Bezerra FA; Sucupira M; Corso G; De Nucci G
Int J Clin Pharmacol Ther; 1998 Dec; 36(12):661-5. PubMed ID: 9877003
[TBL] [Abstract][Full Text] [Related]
6. Sertraline pharmacokinetics and dynamics in adolescents.
Axelson DA; Perel JM; Birmaher B; Rudolph GR; Nuss S; Bridge J; Brent DA
J Am Acad Child Adolesc Psychiatry; 2002 Sep; 41(9):1037-44. PubMed ID: 12218424
[TBL] [Abstract][Full Text] [Related]
7. Concurrent administration of donepezil HCl and sertraline HCl in healthy volunteers: assessment of pharmacokinetic changes and safety following single and multiple oral doses.
Nagy CF; Kumar D; Perdomo CA; Wason S; Cullen EI; Pratt RD
Br J Clin Pharmacol; 2004 Nov; 58 Suppl 1(Suppl 1):25-33. PubMed ID: 15496220
[TBL] [Abstract][Full Text] [Related]
8. The pharmacokinetics of sertraline in overdose and the effect of activated charcoal.
Cooper JM; Duffull SB; Saiao AS; Isbister GK
Br J Clin Pharmacol; 2015 Feb; 79(2):307-15. PubMed ID: 25155462
[TBL] [Abstract][Full Text] [Related]
9. The relation between dosage, serum concentrations, and clinical outcome in children and adolescents treated with sertraline: a naturalistic study.
Taurines R; Burger R; Wewetzer C; Pfuhlmann B; Mehler-Wex C; Gerlach M; Egberts K
Ther Drug Monit; 2013 Feb; 35(1):84-91. PubMed ID: 23318280
[TBL] [Abstract][Full Text] [Related]
10. Compartmental modeling and simplified quantification of [¹¹C]sertraline distribution in human brain.
Kim JW; Lee JS; Kim SJ; Hoigebazar L; Shin KH; Yu KS; Ahn W; Jeong JM; Lee DS
Arch Pharm Res; 2012 Sep; 35(9):1591-7. PubMed ID: 23054716
[TBL] [Abstract][Full Text] [Related]
11. Prediction of clinical response based on pharmacokinetic/pharmacodynamic models of 5-hydroxytryptamine reuptake inhibitors in mice.
Kreilgaard M; Smith DG; Brennum LT; Sánchez C
Br J Pharmacol; 2008 Sep; 155(2):276-84. PubMed ID: 18552871
[TBL] [Abstract][Full Text] [Related]
12. Population pharmacokinetic modeling of sertraline treatment in patients with Alzheimer disease: the DIADS-2 study.
Li CH; Pollock BG; Lyketsos CG; Vaidya V; Drye LT; Kirshner M; Sorisio D; Bies RR;
J Clin Pharmacol; 2013 Feb; 53(2):234-9. PubMed ID: 23436269
[No Abstract] [Full Text] [Related]
13. Comparative bioavailability/ bioequivalence of two different sertraline formulations: a randomised, 2-period x 2-sequence, crossover clinical trial in healthy volunteers.
Almeida S; Portolés A; Terleira A; Filipe A; Cea E; Caturla MC
Arzneimittelforschung; 2005; 55(4):191-7. PubMed ID: 15901041
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a generic physiologically based pharmacokinetic model for lineshape analysis.
Peters SA
Clin Pharmacokinet; 2008; 47(4):261-75. PubMed ID: 18336055
[TBL] [Abstract][Full Text] [Related]
15. Serotonin reuptake inhibitors: bioequivalence of sertraline capsules.
Koytchev R; Ozalp Y; Erenmemisoglu A; van der Meer MJ; Alpan RS
Arzneimittelforschung; 2004 Sep; 54(9A):629-33. PubMed ID: 15497672
[TBL] [Abstract][Full Text] [Related]
16. Effect of proton pump inhibitors on the serum concentrations of the selective serotonin reuptake inhibitors citalopram, escitalopram, and sertraline.
Gjestad C; Westin AA; Skogvoll E; Spigset O
Ther Drug Monit; 2015 Feb; 37(1):90-7. PubMed ID: 24887634
[TBL] [Abstract][Full Text] [Related]
17. Bioequivalence study of 50 mg sertraline tablets in healthy Thai volunteers.
Niyomnaitham S; Chatsiricharoenkul S; Sathirakul K; Pongnarin P; Kongpatanakul S
J Med Assoc Thai; 2009 Sep; 92(9):1229-33. PubMed ID: 19772184
[TBL] [Abstract][Full Text] [Related]
18. A positron emission tomography microdosing study with sertraline in healthy volunteers.
Shin KH; Kim KP; Lim KS; Kim JW; Lee YS; Yang BY; Lee JS; Jung JM; Yoon SH; Jang IJ; Yu KS
Int J Clin Pharmacol Ther; 2012 Mar; 50(3):224-32. PubMed ID: 22373835
[TBL] [Abstract][Full Text] [Related]
19. Quantification of sertraline maternal/fetal ratio and amniotic fluid concentration using a pregnancy physiologically based pharmacokinetic model.
Lartey D; Jateng D; Li M; Nguyen C; Crentsil V; Beitz J; George B
Br J Clin Pharmacol; 2023 Jun; ():. PubMed ID: 37312614
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of sertraline in relation to genetic polymorphism of CYP2C19.
Wang JH; Liu ZQ; Wang W; Chen XP; Shu Y; He N; Zhou HH
Clin Pharmacol Ther; 2001 Jul; 70(1):42-7. PubMed ID: 11452243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
